Beroni Group Limited Approval for R&D Rebate for Anti-Cancer Drug PENAO

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has been approved by the Australian government for the annual 43.5% R&D rebate of eligible expenditure.

The approval also includes R&D overseas activities so long as the total overseas expenditure claim over the life of the R&D activities is less than the expected total expenditure on the Australian R&D activities to which they are scientifically linked.

The PENAO drug manufacture is expected to complete in the first half of 2022. Raw materials have been procured, familiarization studies have been completed and optimization work is progressing well at Aurigene Pharmaceutical Services Ltd, India.

"Aurigene is delighted to partner with PENAO Pty Ltd. In the past 18 years of our work, a key therapy area has been anticancer drug discovery and clinical development. Our technical and infrastructure capabilities provide an integrated drug substance and drug product program for PENAO." said Ravi Venkataramanan, CEO of Aurigene Pharmaceutical Services Ltd, a wholly-owned subsidiary of Dr. Reddy's Laboratories Limited (BOM:500124) (NYSE:RDY).

"We are pleased to receive the Australian government's support for our R&D activities, and we hope that the annual rebate signals to investors the rigorous due diligence conducted by the Australian government and our commitment to develop the PENAO drug to potentially meet the unmet medical need of millions of cancer patients worldwide" said Jacky Zhang, CEO of Beroni Group.



About Beroni Group Limited:

Beroni Group (NSX:BTG) (OTCMKTS:BNIGF) is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, China and Japan. To learn more about Beroni, please visit www.beronigroup.com.



Source:
Beroni Group Limited



Contact:
Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: BNIGF@dgipl.com

News Provided by ABN Newswire via QuoteMedia

The Conversation (0)
Stack of gold bars with red downward arrow on white background.

Gold Price Hits 14 Month Low as Fed Rate Hike Fears Strengthen US Dollar

The gold price continued its downward decline Friday (November 20) as investors reassessed US Federal Reserve policy, raising questions about whether the precious metal's longer-term rally can regain momentum.The fall representing a 14-month low forced the yellow metal in sight of the US$3,500... Keep Reading...
Steve Barton, mine site.

Steve Barton: Gold, Silver Selloff Not Over, My Next Price Targets

Steve Barton, host of In It To Win It, shares his thoughts on gold and silver's recent price declines, saying he sees further downward momentum ahead. "I don't think this level is going to hold," he said about gold. "I think we're going back to this zone right here, which is around US$3,350 to... Keep Reading...
Red world map with declining financial graph lines and bar charts.

Are We in a Recession? Predictions, Signs and Strategies

"Never miss out on an opportunity like a recession" — Jack Welch, former chair and CEO of General Electric.US President Donald Trump’s plans to overhaul the current global trade structure through sweeping tariffs have once again ignited recession fears. With both businesses and consumers... Keep Reading...
Joe Cavatoni, gold bars.

Joe Cavatoni: Gold Outlook Solid, Top Price Drivers for 2027

Joe Cavatoni, senior market strategist, Americas, at the World Gold Council, shares his thoughts on gold's move below US$4,000 per ounce and what's driving the yellow metal. "Right now (I'm) closely watching what's going to play out in the rate market, how bonds are going to perform and also... Keep Reading...
Gareth Soloway, gold, silver and Bitcoin.

Gareth Soloway: Gold, Silver, Bitcoin and More — My Price Calls for 2027

Gareth Soloway, chief market strategist at VerifiedInvesting.com, shares his outlook for gold, silver, oil and Bitcoin prices in 2027, including key price points he's watching. He also gives his thoughts on gold in the near term, noting that holding above US$3,885 per ounce — a level gold has... Keep Reading...

Interactive Chart

Latest Press Releases

Related News